Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 9/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | TPMT | P51580 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SELL | P14151 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SELP | P16109 | 1/20 | 0.31 |
| ▸ | FUT4 | P22083 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17326823 | 0.64 | CA12 (0.42) | TTRCA12CA1CA2CA7 | |
| SCHEMBL31456900 | 0.60 | MEN1 (0.52) | TTRCA12CA1CA2CA7 | |
| SCHEMBL28508926 | 0.60 | MEN1 (0.52) | TTRCA12CA1CA2CA7 | |
| SCHEMBL22982 | 0.59 | CA12 (0.65) | TTRCA12CA1CA2CA7 | |
| SCHEMBL26189 | 0.59 | CA12 (0.65) | TTRCA12CA1CA2CA7 | |
| SCHEMBL10064450 | 0.58 | TTR (0.51) | TTRCA12CA1CA2CA7 | |
| Cyclohexane SCHEMBL30007532 | 0.57 | CA12 (0.55) | TTRCA12CA1CA2CA7 | |
| SCHEMBL29659433 | 0.57 | CA12 (0.48) | TTRCA12CA1CA2CA7 | |
| SCHEMBL335300 | 0.57 | CA12 (0.48) | TTRCA12CA1CA2CA7 | |
| SCHEMBL31437041 | 0.57 | TTR (0.49) | TTRCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725396-B2 | Active material, and sodium ion battery and lithium ion battery using the same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2017-08-08 | — | — | US | disclosed |
| US-20150357631-A1 | ACTIVE MATERIAL, AND SODIUM ION BATTERY AND LITHIUM ION BATTERY USING THE SAME | OSAKA UNIVERSITY (JP) | 2015-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150357631-A1 | ACTIVE MATERIAL, AND SODIUM ION BATTERY AND LITHIUM ION BATTERY USING THE SAME | CACNA1I, CA3, CACNA1G | TTR 1704/4885CA12 49/4885CA1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.